| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S1470-2045(02)00731-3 |
| P698 | PubMed publication ID | 12067807 |
| P2093 | author name string | Hans-Jörg Senn | |
| Gregor Fürstenberger | |||
| P2860 | cites work | Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells | Q28139221 |
| Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 | ||
| The IGF/IGFBP system in CNS malignancy | Q30320940 | ||
| The role of the IGF-I receptor in the growth and transformation of mammalian cells. | Q33721490 | ||
| Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis | Q33853206 | ||
| IGF-I receptor signalling in transformation and differentiation | Q33918687 | ||
| The IGF axis and hepatocarcinogenesis | Q33918694 | ||
| The effects of insulin-like growth factors on tumorigenesis and neoplastic growth | Q33945357 | ||
| New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia | Q34009691 | ||
| Role of the insulin-like growth factor family in cancer development and progression | Q34038191 | ||
| Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study | Q34065827 | ||
| Signalling pathways involved in antiproliferative effects of IGFBP-3: a review | Q34263336 | ||
| Insulin-like growth factor I and prostate cancer | Q34303679 | ||
| Insulin, insulin-like growth factors and colon cancer: a review of the evidence | Q34428652 | ||
| Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia | Q34445822 | ||
| Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study | Q34473008 | ||
| Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts | Q36653985 | ||
| Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer | Q36691983 | ||
| Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor | Q36696132 | ||
| Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth | Q40752579 | ||
| c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. | Q40792572 | ||
| Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. | Q40817530 | ||
| Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics | Q41010710 | ||
| The role of the insulin-like growth factor system in human cancer | Q41035980 | ||
| The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action | Q41175229 | ||
| Insulin-like growth factor binding proteins and their role in controlling IGF actions | Q41489957 | ||
| Structure and function of the insulin-like growth factor I receptor | Q41727239 | ||
| The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene | Q41727244 | ||
| A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women | Q43606525 | ||
| Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients | Q44601066 | ||
| Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas | Q48915278 | ||
| Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. | Q50537419 | ||
| Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. | Q53404629 | ||
| Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras. | Q53407295 | ||
| Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. | Q53417183 | ||
| Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. | Q55034277 | ||
| Circulating concentrations of insulin-like growth factor I and risk of breast cancer | Q57751183 | ||
| Acromegaly and gastrointestinal cancer | Q68003663 | ||
| Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer | Q68766854 | ||
| Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer | Q70565385 | ||
| Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients | Q71513576 | ||
| Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer | Q71703891 | ||
| Suramin decreases circulating levels of insulin-like growth factor-I | Q72382482 | ||
| Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells | Q73446751 | ||
| Acromegaly, colonic polyps and carcinoma | Q73709678 | ||
| Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells | Q73750485 | ||
| P433 | issue | 5 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 298-302 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | Insulin-like growth factors and cancer | |
| P478 | volume | 3 |
| Q36375083 | A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer |
| Q34532397 | A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma |
| Q37212940 | A polymorphic repeat in the IGF1 promoter influences the risk of endometrial cancer. |
| Q37872742 | AMP-activated protein kinase modulators: a patent review (2006 - 2010). |
| Q30424348 | Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells |
| Q36580450 | Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. |
| Q37165350 | Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody |
| Q49145918 | Alpha-catenin is required for IGF-I-induced cellular migration but not invasion in human colonic cancer cells |
| Q35596741 | Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes |
| Q44908739 | Altered metabolic profiles among older mothers with a history of preeclampsia |
| Q79858875 | Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin-like growth factor receptor type 1 |
| Q33927273 | Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway. |
| Q97525750 | Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance |
| Q36123803 | Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses |
| Q34893448 | Association between insulin-like growth factor binding protein-3 promoter polymorphism of -1590 C>A and lung cancer susceptibility in a Chinese Han population |
| Q35596135 | Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration |
| Q38995450 | Associations of Calcium and Milk Product Intakes with Incident, Sporadic Colorectal Adenomas. |
| Q35735725 | Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis |
| Q53348325 | Breast cancer risk after caloric restriction during the 1944-1945 Dutch famine. |
| Q37175481 | C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth |
| Q64135521 | Cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data |
| Q35792015 | Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction |
| Q46043891 | Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis |
| Q35239623 | Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer |
| Q79366823 | Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer |
| Q86066391 | Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1 |
| Q35925906 | Clinical significance of insulin-like growth factor gene polymorphisms with survival in patients with gastrointestinal stromal tumors |
| Q43935037 | Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer |
| Q37203589 | Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis |
| Q92893121 | Clinical significance of serum IGFBP-3 in colorectal cancer |
| Q37392688 | Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma |
| Q41293132 | Combined evaluation of IGF-1 and IGFBP-3 as an index of efficacy and safety in growth hormone treated patients |
| Q40423713 | Comparative microarray analysis of basal gene expression in mouse Hepa-1c1c7 wild-type and mutant cell lines |
| Q48281213 | Comparison of telomere length and insulin-like growth factor-binding protein 7 promoter methylation between breast cancer tissues and adjacent normal tissues in Turkish women. |
| Q24626074 | Controversies in the definition and treatment of idiopathic short stature (ISS) |
| Q37277344 | Critical prosurvival roles for C/EBP beta and insulin-like growth factor I in macrophage tumor cells |
| Q64269559 | Dairy Products: Is There an Impact on Promotion of Prostate Cancer? A Review of the Literature |
| Q54090322 | Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway. |
| Q30410016 | Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways |
| Q100760609 | Diet-dependent acid load and the risk of colorectal cancer and adenoma: a case-control study |
| Q35659602 | Dietary fat, fiber, and carbohydrate intake and endogenous hormone levels in premenopausal women |
| Q54573044 | Differential gene expression between human schwannoma and control Schwann cells. |
| Q91666107 | Diseases of Civilization - Cancer, Diabetes, Obesity and Acne - the Implication of Milk, IGF-1 and mTORC1 |
| Q33979359 | Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse |
| Q38317198 | Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding |
| Q44506162 | Effect of glutamine on glutathione, IGF-I, and TGF-beta 1. |
| Q37010354 | Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer |
| Q87367003 | Effects of parenteral nutrition with and without GH on the GH/IGF-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis |
| Q44567179 | Effects of plasmid-mediated growth hormone-releasing hormone supplementation on LL-2 adenocarcinoma in mice |
| Q91924502 | Endocrine regulation of regeneration: Linking global signals to local processes |
| Q37360520 | Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and Prognosis |
| Q55474697 | Energy balance, insulin resistance biomarkers, and breast cancer risk. |
| Q55223525 | Epigenetic Downregulation and Growth Inhibition of IGFBP7 in Gastric Cancer |
| Q92840072 | Estrogen receptor β inhibits prostate cancer cell proliferation through downregulating TGF-β1/IGF-1 signaling |
| Q37548270 | Evaluation of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Expression Levels in Patients with Chronic Lymphocytic Leukemia. |
| Q35607521 | Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma |
| Q37245469 | Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer |
| Q35753837 | Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients |
| Q42459590 | Expression of insulin-like growth factor-I receptor in primary cutaneous carcinomas |
| Q35147070 | Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements |
| Q36053004 | Extrapituitary effects of the growth hormone-releasing hormone. |
| Q37353937 | Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment |
| Q28186796 | Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21) |
| Q36472257 | GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer |
| Q38246143 | Ganitumab for the treatment of small-cell lung cancer |
| Q90216380 | Gene expression and prognosis of insulin‑like growth factor‑binding protein family members in non‑small cell lung cancer |
| Q41382285 | Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections |
| Q53370638 | Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. |
| Q35009490 | Genes, growth factors and acanthosis nigricans. |
| Q36581469 | Genetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancer |
| Q47694584 | Genetic variation in insulin pathway genes and distal colorectal adenoma risk |
| Q30487836 | Genetic variation in insulin-like growth factors and brain tumor risk |
| Q34316522 | Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients |
| Q34836999 | Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines |
| Q37503141 | Growth effects of insulin and insulin analogues |
| Q35803398 | Growth hormone deficiency and related disorders: insights into causation, diagnosis, and treatment |
| Q80943621 | Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children |
| Q35171723 | Growth hormone treatment and risk of malignancy |
| Q37367986 | Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review. |
| Q34367110 | Growth hormone treatment: cancer risk |
| Q35185769 | Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists |
| Q46134310 | H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway |
| Q36387760 | Height at diagnosis and birth-weight as risk factors for osteosarcoma |
| Q26786940 | High Birth Weight Increases the Risk for Bone Tumor: A Systematic Review and Meta-Analysis |
| Q91684042 | Higher diet-dependent acid load is associated with risk of breast cancer: Findings from the sister study |
| Q34360616 | Human prostate cancer risk factors |
| Q35932387 | Hypoxia-inducible factors and hypoxic cell death in tumour physiology |
| Q34958659 | IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer |
| Q45970266 | IGF-1R inhibition: right direction, wrong pathway? |
| Q42516001 | IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis. |
| Q40623583 | IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase |
| Q38042423 | IGF-IR and its inhibitors in gastrointestinal carcinomas (Review). |
| Q89053644 | IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells |
| Q33941364 | IRS-2 G1057D polymorphism in Turkish patients with colorectal cancer |
| Q33648770 | IRS-2 rs1805097 polymorphism is associated with the decreased risk of colorectal cancer |
| Q58809603 | Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach |
| Q26740210 | Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung Cancer |
| Q42799629 | In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase |
| Q39201195 | Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer |
| Q37181675 | Induction of apoptosis and the regulation of ErbB signaling by laminarin in HT-29 human colon cancer cells |
| Q91723095 | Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting |
| Q33925323 | Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach |
| Q35971416 | Insulin analogs and cancer |
| Q30870542 | Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major |
| Q34334497 | Insulin-like growth factor 1 stimulates KCl cotransport, which is necessary for invasion and proliferation of cervical cancer and ovarian cancer cells |
| Q33845203 | Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival |
| Q46364420 | Insulin-like growth factor signaling regulates developmental trajectory associated with diapause in embryos of the annual killifish Austrofundulus limnaeus. |
| Q51837006 | Insulin-like growth factor signaling regulates the timing of sensory cell differentiation in the mouse cochlea. |
| Q56866855 | Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast c |
| Q47936787 | Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17. |
| Q37334160 | Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer |
| Q36074111 | Insulin-like growth factor-1 signaling in renal cell carcinoma |
| Q39214150 | Insulin-like growth factor-II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse. |
| Q37047067 | Insulin-like growth factor: current concepts and new developments in cancer therapy |
| Q36526256 | Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence? |
| Q35521421 | Intestinal adaptation after massive intestinal resection |
| Q33920800 | Investigational agents in development for the treatment of ovarian cancer |
| Q47279238 | Is body size associated with ovarian cancer in southern Chinese women? |
| Q39740037 | Is rate of skin wound healing associated with aging or longevity phenotype? |
| Q35039264 | Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis |
| Q24303485 | Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung |
| Q24309176 | Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor |
| Q83611068 | Local insulin-like growth factor-I of ventral prostate was upregulated during long-term castration and may function through the autocrine system |
| Q39007160 | Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression |
| Q43582537 | Lycopene effects contributing to prostate health |
| Q36057462 | MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line |
| Q89869669 | Marked structural rearrangement of mannose 6-phosphate/IGF2 receptor at different pH environments |
| Q55004324 | Maternal IGF1 and IGF1R polymorphisms and the risk of spontaneous preterm birth. |
| Q40159420 | Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix. |
| Q37151297 | Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC. |
| Q27348974 | Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages |
| Q35164959 | Methylation status of insulin-like growth factor-binding protein 7 concurs with the malignance of oral tongue cancer |
| Q35820533 | Molecular Targets in Biliary Carcinogenesis and Implications for Therapy |
| Q79079262 | Molecular cloning of a constitutional t(7;22) translocation associated with risk of hematological malignancy |
| Q36337268 | Molecular imaging of insulin-like growth factor 1 receptor in cancer |
| Q26747089 | Molecular signaling involving intrinsically disordered proteins in prostate cancer |
| Q60909519 | Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update |
| Q23918758 | Multiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosis |
| Q61862895 | Mutual regulation between IGF-1R and IGFBP-3 in human corneal epithelial cells |
| Q28082524 | New perspectives on targeted therapy in ovarian cancer |
| Q35340995 | No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer |
| Q37782097 | Novel targeted therapies in the treatment of soft-tissue sarcomas |
| Q34005616 | Novel treatments for cancer cachexia |
| Q35131269 | OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells |
| Q41230156 | Obesity provides a permissive milieu in inflammation-associated carcinogenesis: analysis of insulin and IGF pathways |
| Q36922072 | Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression |
| Q35911350 | Personalized therapy in endometrial cancer: challenges and opportunities |
| Q33652095 | Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents |
| Q34328099 | Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies |
| Q37605867 | Physical activity, obesity and risk for esophageal adenocarcinoma. |
| Q33645688 | Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study |
| Q44159735 | Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer |
| Q24796587 | Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice |
| Q43072087 | Protein tyrosine kinase pathway-derived ROS/NO productions contribute to G2/M cell cycle arrest in evodiamine-treated human cervix carcinoma HeLa cells |
| Q37243718 | Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults |
| Q37625242 | Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk |
| Q35535296 | Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation |
| Q35783253 | Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. |
| Q35995683 | Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. |
| Q46706696 | Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women |
| Q36127622 | Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma. |
| Q26798101 | Steatosis and hepatitis C |
| Q52646119 | Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma. |
| Q33280034 | Systemic administration of IGF-I enhances healing in collagenous extracellular matrices: evaluation of loaded and unloaded ligaments |
| Q34654685 | TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1. |
| Q38216009 | Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives |
| Q33951057 | Targeting insulin-like growth factor axis in hepatocellular carcinoma |
| Q38708848 | Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer |
| Q33575740 | Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment |
| Q37588787 | Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling |
| Q36920776 | Tea beverage in chemoprevention and chemotherapy of prostate cancer. |
| Q34082468 | The Association between Polymorphismsin Insulin and Obesity Related Genesand Risk of Colorectal Cancer |
| Q35990291 | The association between circulating IGF1, IGFBP3, and calcium: results from NHANES III. |
| Q34984126 | The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial |
| Q54867290 | The concept of multiple hormonal dysregulation. |
| Q34073953 | The emerging role of KCl cotransport in tumor biology |
| Q36997962 | The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors |
| Q34699785 | The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis |
| Q33596263 | The impact of breakfast in metabolic and digestive health |
| Q42981023 | The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. |
| Q36164909 | The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence |
| Q35819252 | The insulin-like growth factor system: towards clinical applications |
| Q30244095 | The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies |
| Q84563006 | The molecular basis of IGF-II/IGF2R recognition: a combined molecular dynamics simulation, free-energy calculation and computational alanine scanning study |
| Q34248711 | The p53 network: cellular and systemic DNA damage responses in aging and cancer |
| Q26796377 | The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells |
| Q38097400 | The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer |
| Q43147470 | Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma. |
| Q35575283 | Transient caloric restriction and cancer risk (The Netherlands). |
| Q36352613 | Understanding why aspirin prevents cancer and why consuming very hot beverages and foods increases esophageal cancer risk. Controlling the division rates of stem cells is an important strategy to prevent cancer |
| Q36577009 | Use of growth hormone in children |
| Q34627943 | Using epidemiology and genomics to understand osteosarcoma etiology |
| Q34770011 | WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer |
| Q36078983 | miR-15b/16-2 deletion promotes B-cell malignancies |
| Q34092121 | miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma |
Search more.